We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
+14.79%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$163M
AUM Growth
+$18.8M
Cap. Flow
-$1.23M
Cap. Flow %
-0.76%
Top 10 Hldgs %
55.53%
Holding
48
New
2
Increased
7
Reduced
37
Closed
1

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.37M
2
SHEL icon
Shell
SHEL
+$360K
3
ABT icon
Abbott
ABT
+$341K
4
SYK icon
Stryker
SYK
+$215K
5
SBUX icon
Starbucks
SBUX
+$195K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.71%
2 Financials 11.93%
3 Healthcare 11.74%
4 Industrials 8.04%
5 Technology 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
1
Home Depot
HD
$332B
$51.8M 31.83%
164,093
-315
-0.2% -$96K
NVO
2
Novo Nordisk
NVO
$228B
$5.03M 3.09%
74,298
-2,316
-3% -$136K
ABT icon
3
Abbott
ABT
$183B
$4.52M 2.78%
41,210
+3,295
+9% +$341K
MCD icon
4
McDonald's
MCD
$191B
$4.48M 2.75%
17,012
-478
-3% -$126K
AJG icon
5
Arthur J. Gallagher & Co
AJG
$65.9B
$4.31M 2.65%
22,860
-1,181
-5% -$221K
PG icon
6
Procter & Gamble
PG
$335B
$4.18M 2.57%
27,555
-857
-3% -$120K
CVX icon
7
Chevron
CVX
$383B
$4.07M 2.5%
22,657
-2,219
-9% -$387K
SHEL icon
8
Shell
SHEL
$250B
$4.01M 2.47%
70,485
+6,526
+10% +$360K
GILD icon
9
Gilead Sciences
GILD
$163B
$4M 2.46%
46,580
+17,238
+59% +$1.37M
HON icon
10
Honeywell
HON
$76.7B
$3.98M 2.45%
19,713
-551
-3% -$105K
JPM icon
11
JPMorgan Chase
JPM
$933B
$3.94M 2.42%
29,399
-830
-3% -$105K
COP icon
12
ConocoPhillips
COP
$145B
$3.93M 2.42%
33,331
-1,786
-5% -$217K
MSFT icon
13
Microsoft
MSFT
$3.35T
$3.92M 2.41%
16,347
-455
-3% -$109K
WFC icon
14
Wells Fargo
WFC
$258B
$3.9M 2.4%
94,552
-3,552
-4% -$157K
UPS icon
15
United Parcel Service
UPS
$89.5B
$3.85M 2.37%
22,174
-628
-3% -$109K
DD icon
16
DuPont de Nemours
DD
$18.7B
$3.63M 2.23%
42,195
-1,136
-3% -$90.8K
LHX icon
17
L3Harris
LHX
$50.7B
$3.6M 2.21%
17,283
-458
-3% -$103K
PEP icon
18
PepsiCo
PEP
$191B
$3.05M 1.87%
16,884
-503
-3% -$89.7K
CMCSA icon
19
Comcast
CMCSA
$84B
$3.04M 1.87%
86,999
-2,099
-2% -$69.4K
MCHP icon
20
Microchip Technology
MCHP
$40.7B
$3.03M 1.86%
43,140
-1,118
-3% -$77K
ADI icon
21
Analog Devices
ADI
$179B
$3.02M 1.85%
18,390
-727
-4% -$113K
AMGN icon
22
Amgen
AMGN
$209B
$2.71M 1.66%
10,303
-366
-3% -$98.1K
BAC icon
23
Bank of America
BAC
$433B
$2.68M 1.64%
80,839
-2,671
-3% -$92K
JNJ icon
24
Johnson & Johnson
JNJ
$617B
$2.62M 1.61%
14,850
-492
-3% -$85K
ACN icon
25
Accenture
ACN
$99.9B
$2.5M 1.54%
9,388
-245
-3% -$67.8K

Similar funds

Brookmont Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Brookmont Capital Management held 48 positions worth $163M, up 13% from $144M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Brookmont Capital Management's Q4 2022 filing shows 2 new, 7 increased, 37 reduced and 1 closed positions. Its largest new stake was Stryker: 946 shares worth $231K. The largest sale was Eastman Chemical, an estimated $610K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Brookmont Capital Management's largest Q4 2022 buy was Stryker: 946 shares worth $231K.
  • Brookmont Capital Management added most to Gilead Sciences in Q4 2022, an estimated $1.37M increase.
  • Brookmont Capital Management's biggest Q4 2022 reduction was Eastman Chemical, cutting an estimated $610K.
  • Brookmont Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2022, selling an estimated $207K.
  • Brookmont Capital Management's ten largest holdings make up 56% of its $163M portfolio in Q4 2022.
  • Brookmont Capital Management opened 2 new positions and closed 1 in Q4 2022.
  • Brookmont Capital Management's portfolio value rose 13% quarter-over-quarter to $163M.

Based on Brookmont Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.